NCT04234100View on ClinicalTrials.gov

Bioavailability of Hesperidine and Narirutin From Orange Juice to Identify Metabotypes in Hypertension

NACompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

February 24, 2020

Primary Completion Date

September 22, 2020

Study Completion Date

September 22, 2020

Conditions
Blood PressureHypertension
Interventions
OTHER

Orange juice rich in hesperidin and narirutin

The product is a concentrated orange juice provided by the CITRUS Department of Florida (USA: www.FloridaCitrus.org).

Trial Locations (1)

Unknown

Centro Tecnológico de Nutrición y Salud (Eurecat-Reus), Reus

All Listed Sponsors
lead

Technological Centre of Nutrition and Health, Spain

OTHER

NCT04234100 - Bioavailability of Hesperidine and Narirutin From Orange Juice to Identify Metabotypes in Hypertension | Biotech Hunter | Biotech Hunter